Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin

Publication | Open Access

DOI Full Paper Access

131

Citations

References

2003

Year

Victor A. Gault, Finbarr O’Harte, Patrick Harriott, MH Mooney, BD Green, Peter R. Flatt

Diabetologia

Metabolic SyndromeInsulin SignalingBiochemistryMedicineInsulin ManagementPhysiologyDiabetesGip AntagonistMetabolic RegulationEndocrinologyMetabolismInsulin SecretionMetabolic SignalingPharmacologyMajor Physiological IncretinGastrointestinal Peptide HormoneHealth Sciences